Ann: Updated Shareholder / Investor Presentation, page-70

What I took from the meeting

- cash flow positive first week of June
- increasing orders from existing customers
- have found themselves solving customer's problems re chemical processes, are becoming the go-to supplier.
- focus is on working with key global players, not smaller manufacturers
- working closely with their customers is their number one priority - to make sure production lines are not affected during the transition to Alexium formulas.
- the FR process is significantly less toxic, flexible to suit changing material types, and cheaper.
- AJX are very aware that they should not underprice their product, as they hold advantages across multiple dimensions
- they are very conscious of the competitive market plan i.e. - if they cannot deliver a superior product cheaper than the incumbent, they don't go there.
- their margins we terrible in the Q3 FY17, as they decided to price their Alixcool product at a price point that was assuming that they were going to buy their raw materials in bulk. At that point their COGS was higher due to the smaller volume. They are now buying their raw materials in bulk, and their margins are great.
- getting ready for Pegasus. Revenue will flow second half of calendar year.
- ramping up for bedding in Europe.

Dirk and Bob Brookins were impressive - it felt like their impression was 'no dramas - we are getting on with things. Of course the revenue is skyrocketing'.